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Abstract A peptide representing a putative fusion domain of 
fertilin, a sperm surface protein involved in sperm-egg fusion was 
synthesized. Its interaction with model membranes was char-
acterized and compared with that of a synthetic peptide 
representing the fusion peptide of HIV-2rod gp41. The fertilin 
fusion peptide interaction with lipid vesicles is dependent upon the 
presence of negatively charged lipids in the membrane. Its 
fusogenic activity does not require PE and is not inhibited by 
addition of lysolecithin in the medium. These conditions are quite 
opposite to those obtained with the HIV2 peptide and suggest 
that the lipid mixing mediated by the two peptides corresponds to 
two different molecular mechanisms. 
© 1979 Federation of European Biochemical Societies. 
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1. Introduction 
Membrane fusion is an essential event in cell biology and 
plays a crucial role in important physiological processes such 
as endocytosis/exocytosis, fertilization or viral infection. Stud-
ies on the molecular mechanism of viral fusion have allowed 
identification and characterization of a specific fusion protein 
[1]. One of the main characteristics of most viral fusion pro-
teins is the presence of a relatively hydrophobic amino acid 
stretch, often referred as 'fusion peptide'. The biophysical 
properties of such fusion peptides, especially the mechanism 
of their membrane action, are the subject of intense research 
P-6]. 
Recently, Blobel et al. [7,8] have proposed that fertilin, a 
protein located on the surface of guinea pig sperm, is impli-
cated in the process of sperm-egg fusion. This protein is com-
posed of two subunits (a and (3) and shares many character-
istics in common with viral fusion proteins, suggesting that 
fusion events which occur during fertilization and penetration 
of enveloped viruses into host cells may share a common 
mechanism. In this context, particular interest exists in iden-
tifying and characterizing a fusion peptide in the sperm sur-
face protein. The sequence recently suggested as a likely can-
didate for this role comprises residue 89-111 of the a-subunit 
of fertilin [8]. This region fulfills all three criteria of an inter-
nal fusion peptide: (1) located in a membrane anchored sub-
unit ; (2) relatively hydrophobic and (3) capable of being mod-
elled as a 'sided' oc-helix with most of the bulky hydrophobic 
residues on one face and negatively charged amino acids on 
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the other [9]. Moreover, this peptide has been shown to inter-
act with the membrane bilayer of liposomes and to induce 
lipid mixing of POPC/POPG/PE large unilamellar vesicles 
[10]. The resemblance between a viral fusion peptide and the 
fertilin fusion peptide may therefore not be entirely coinciden-
tal. 
In the present work, we studied the ability of a synthetic 
peptide corresponding to the putative fusion peptide of fertil-
in : NH2-His-Pro-Ile-Gln-Ile-Ala-Ala-Phe-Leu-Ala-Arg-Ile-
Pro-Pro-Ile-Ser-Ser-Ile-Gly-Thr-Cys-Ile-Leu-Lys-COOH, to 
destabilize and to induce lipid mixing of large unilamellar 
vesicles made of lipids mimicking the plasma membrane. 
These properties of the fertilin fusion peptide were compared 
with those of a synthetic peptide corresponding to the N-ter-
minus extremity of gp41 of HIV2rod virus: NH2-Gly-Val-
Phe-Val-Leu-Gly-Phe-Leu-Gly-Phe-Leu-Ala-Thr-Ala-Gly-Ser-
Ala-Met-Gly-Ala-Ala-Ser-Leu-Thr-Val-COOH. A compari-
son of the role of negatively charged lipids in the membrane 
vesicles, of lysoPC in the external medium and of tempera-
ture, on the interaction of these peptides with lipids suggests 
that the two peptide-induced lipid mixing processes have dif-
ferent mechanisms. 
2. Materials and methods 
2.1. Materials 
Egg phosphatidylethanolamine (PE), egg phosphatidylcholine (PC), 
sphingomyelin (SM), phosphatidylserine (PS), phosphatidylinositol 
(PI), phosphatidic acid (PA) and cholesterol (Choi) were purchased 
from Sigma Chemical Co. (St Louis, MO, USA). JV-(Nitrobenzo-2-
oxa-l,3-diazol)phosphatidylethanolamine (NBD-PE) and 7V-(lissamine 
rliodamine B sulfonyl)phosphatidylethanolamine (Rh-PE) were from 
Avanti Polar Lipids Inc. (Birmingham, AL, USA). 
Calcein (Sigma) was purified by chromatography on Sephadex LH-
20 (Pharmacia). Calcein was loaded on the column as a sodium salt 
solution and eluted with water at neutral pH. The concentration of 
calcein was determined spectrophotometrically by using 7.0 X 104 M_1 
cm-1 as the molar extinction coefficient at 492 nm [11]. 
HPLC-purified synthetic peptides representing the sequence of the 
fertilin and HIV2 fusion peptides in their amide form were purchased 
from Chiron mimotope. The peptides were dissolved in DMSO at a 
concentration of 1 mg/ml and stored at 4°C. 
2.2. Vesicle preparation 
Routinely, egg PC and egg PE were dissolved in chloroform at the 
desired concentrations and the solution was dried under a stream of 
nitrogen to deposit a thin lipid film on the inside of a glass tube. The 
film was further subjected to vacuum evaporation for 2-3 h to remove 
any trace of the solvent. Large unilamellar vesicles (LUV) were pre-
pared by hydrating the dried lipid film with HEPES buffer (10 mM 
HEPES, 150 mM NaCl, 0.1 mM EDTA, 0.02% NaN3, pH 7.4), then 
repeatedly freeze-thawing the suspension five times, and finally extrud-
ing it 10 times through two polycarbonate filters of pore size 0.1 urn 
(Nucleopore Corp., Pleasanton, CA, USA) using an extruder (Lipex 
Biomembranes Inc., Vancouver, Canada) according to the extrusion 
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procedure of Hope et al. [12]. The prepared liposomes were stored at 
4°C until use. 
2.3. Fusion measurements 
Two probes (NBD-PE and Rh-PE) were added to the lipid film and 
LUV were prepared as described above. Liposomes containing both 
probes at 0.6% (molar ratio) each, were mixed with probe free lip-
osomes at a 1:9 molar ratio and a final lipid concentration of 3 X 10~4 
M. Lipid mixing was determined by measuring the fluorescence inten-
sity change resulting from the fluorescence energy transfer between 
NBD-PE and Rh-PE inserted into the lipid bilayer, as described by 
Struck et al. [13]. Briefly, fluorescence energy transfer between the two 
probes is dependent upon their spatial organization, any fusion be-
tween unlabeled and labeled vesicles will result in dilution of the 
probes in the membrane decreasing the energy transfer and increasing 
the fluorescence of NBD-PE. Fluorescence was monitored using an 
SLM 8000 spectrofluorimeter (SLM Instruments Inc., Urbana, IL, 
USA) with excitation and emission slits of 4 nm. The suspensions 
were excited at 470 nm and the NBD fluorescence was recorded at 
530 nm. Experiments were conducted in a 1-ml stirred cuvette, with 
right angle illumination. The initial fluorescence of the 1:9 (labeled/ 
unlabeled) suspension was taken as 0% fluorescence and the 100% 
fluorescence was determined using an equivalent concentration of 
vesicles prepared with 0.06% of each fluorescent phospholipid. 
2.4. Leakage measurements 
Liposomes were prepared as described above, except that the dried 
lipid film was rehydrated in buffer containing 62 mM calcein purified 
as described above. After extrusion, liposome-entrapped calcein was 
separated from free calcein on a Sephadex G-50 gel filtration column, 
and eluted with 10 mM HEPES, 150 mM NaCl, 1 mM EDTA buffer, 
pH 7.2. Liposome concentration was estimated by measuring the lipid 
phosphorus content [14]. Leakage from calcein-containing liposomes 
was detected as an increase in fluorescence, resulting from the relief of 
self-quenching upon dilution of the dye into external medium [11,15]. 
Calcein was detected at an excitation wavelength of 490 nm and an 
emission wavelength of 520 nm, employing a slit width of 4nm. The 
fluorescence scale was calibrated by setting the initial fluorescence of 
liposomes to 0% and the fluorescence at infinite probe dilution, after 
adding Triton X-100 (0.1% (v/v)), to 100%. 
In order to explore the influence of vesicle lipid composition 
on lipid mixing, experiments were carried out with different 
lipid mixtures. The percentage of fusion was measured after 
addition of HIV2rod or fertilin peptide to a suspension of 
vesicles of different compositions (Table 1). The total lipid/ 
peptide molar ratio was 40 and the percentage of fusion meas-
ured 20 min after addition of peptide. As previously demon-
strated [2], HIV peptide induces lipid mixing only of lipo-
somes containing PE in their bilayer and the efficiency of 
this fusion process increases with the concentration of PE in 
the lipid bilayer (Table 1). Analysis of data in Table 1 reveals 
that negatively charged lipids like PI or PS greatly increase the 
observed lipid mixing induced by fertilin peptide. Unlike HIV 
peptide, addition of PE to liposomes containing a negatively 
charged lipid (PI or PS) reduces the fusion activity. 
Table 1 confirms a qualitative correlation between the de-
stabilizing efficiency and the fusogenic activity of the two pep-
tides. Addition of the two peptides caused the rapid release of 
the calcein from LUV of PC/PE/SM/PS/PI/PA/Chol (17, 19, 
20, 11, 2, 0.5, 30 wt%), while HIV2rod fusion peptide is less 
efficient in inducing calcein release than fertilin fusion peptide 
(Fig. 3). 
3.1. Effect of temperature 
Lipid mixing induced by HIV2rod fusion peptide depends 
on temperature as shown in Fig. 2A. The fluorescence increase 
between 30 and 40°C is associated with the transition of PE 
from a bilayer to a non-lamellar lipid structure [15]. 
In the presence of fertilin peptide, fusion occurs over a wide 
temperature range (5^5°C) and no increase at the PE tran-
sition temperature could be detected, suggesting that these 
two peptides induced lipid mixing through two different mech-
3. Results 
The fusogenic activity of fertilin peptide was assessed by 
measuring its ability to induce lipid mixing of vesicles contain-
ing the fluorescent probes NBD-PE and Rh-PE and the label 
free vesicles [13] and was compared to the fusogenic activity of 
HIV2rod peptide. Addition of the fertilin peptide to LUV of 
PC/PE/SM/PS/PI/PA/Chol (17, 19, 20, 11, 2, 0.5, 30 wt%) 
results in an effective intervesicular lipid mixing comparable 
to fusion activity of HIV2rod peptide. The effect is concen-
tration dependent and increases with increasing amounts of 
peptide added (Fig. 1). This lipid composition has been chos-
en as the most representative of the plasma membrane. 
3.2. Effect of lysoPC 
It has been previously shown that addition of exogenous 
lysoPC to the medium resulted in concentration-dependent 
inhibition of liposome fusion induced by HIV or SIV fusion 
peptide [16,17]. We assessed the effect of lysoPC in the fusion 
buffer, on lipid mixing induced by HIV2rod and fertilin pep-
tide. Liposomes of PC/PE/SM/PS/PI/PA/Chol (17, 19, 20, 11, 
2, 0.5, 30 wt%) were incubated with various amounts of ly-
soPC at 37°C. After 15 min of incubation, the peptides were 
added to the liposomes, and the NBD-PE fluorescence was 
measured. LysoPC inhibits lipid mixing induced by HIV2rod 
but has no effect on the vesicle fusion induced by fertilin 
peptide even at high concentration ( > 50 u\g) (Fig. 2B). 
Table 1 
Influence of bilayer lipid composition on fusion peptide-induced lipid mixing and release of vesicle contents 
Lipid composition 
Egg PC 
PC/PE (50/50) 
PC/PS (80/20) 
PC/PI (80/20) 
PC/PE/PI (50/30/20) 
PC/PE/PS (50/30/20) 
Plasma membrane lipidsb 
Fertilin-induced lipid 
mixing 
0 
0 
50 
50 
30 
n.d. 
30 
(%f 
Fertilin-induced 
release 
<10 
0 
75 
80 
35 
40 
60 
(%)a 
HIV2rod-induced lipid 
mixing 
0 
50 
0 
0 
30 
n.d. 
30 
(%f 
HIV2rod-induced 
release (%)a 
0 
30 
0 
0 
10 
10 
40 
a% release or % lipid mixing measured 20 min after addition of fusion peptide (10 ug). Lipid concentration was 13 uM. The values in this table 
represent means of five different experiments with a standard deviation of ± 3%. 
bAn artificial mixture of lipids mimicking the composition of the plasma membrane: PC/PE/SM/PS/PI/PA/Chol (17, 19, 20, 11, 2, 0.5, 30 wt%). 
n.d., not determined 
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Fig. 1. Time course of fertilin fusion peptide (A) and HIV2rod peptide (B) induced lipid mixing of large unilamellar vesicles (LUV PC/PE/SM/ 
PS/PI/PA/Chol). Small aliquots of fusion peptide/DMSO solution were added at time =100 s to vesicles at 37°C. Experimental conditions: total 
lipid concentration was 3X10 - 4 M and the peptide concentration (a) = 30 ug/ml, (b) = 20 ug/ml, (c)=15 ug/ml and (d) = 10 ug/ml. Dimethyl 
sulfoxide (DMSO) up to 2% (v/v), which is the maximal concentration used, did not modify the fluorescence. 
4. Discussion 
The hydrophobic region located at the amino-terminal ex-
tremity of transmembrane envelope glycoproteins of several 
enveloped viruses (paramyxo-, orthomyxo-, and retroviruses) 
has been proposed to play a role in the fusion process and is 
referred to as the fusion peptide (for review, see [9]). In HIV-1 
and SIV, this hydrophobic domain is located at the N-termini 
of gp41 and gp32. The presence of a putative fusion peptide in 
the oc-subunit of fertilin, a protein involved in sperm-egg fu-
sion has also been suggested [8]. This peptide is not an N-
terminal peptide and corresponds to a sequence located inter-
nally in the protein (residues from 89 to 111). 
The present data demonstrate that synthetic peptides repre-
senting the putative fusion peptide of fertilin and of HIV2 
gp41 interact with phospholipid bilayers and that binding of 
the peptides to the vesicles is followed by intervesicular lipid 
mixing as demonstrated by the resonance energy transfer as-
say. 
Interaction of fertilin fusion peptide with lipid membrane 
requires the presence of negatively charged lipids in the mem-
brane, since lipid mixing and calcein release were not observed 
from egg PC vesicles or PC/PE vesicles even at a high lipid/ 
peptide molar ratio. The increased effect of fertilin peptide in 
the presence of acidic lipids could be due to increased binding 
of peptide to a negatively charged surface. The absence of 
fertilin peptide-induced fusion and calcein release from neu-
tral vesicles (Table 1) suggests that negative charges are essen-
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Fig. 2. Time course of fertilin fusion peptide and HIV2rod induced calcein release from large unilamellar vesicles (LUV PC/PE/SM/PS/PI/PA/ 
Choi). Small aliquots of fusion peptide/DMSO solution were added at time= 100 s to calcein-loaded vesicles at 37°C. Experimental conditions: 
total lipid concentration was 3X 10~4 M and the peptide concentration 1.3 X 10~5 M. Dimethyl sulfoxide (DMSO) up to 2% (v/v), which is the 
maximal concentration used, did not modify the fluorescence. 
tial for the peptide either to bind at the vesicle surface or to 
induce a conformational change which would allow its inser-
tion in the lipid membrane. The characterisation of secondary 
structures of this peptide as a function of the presence of 
negatively charged vesicles is under investigation using Four-
ier transform infrared spectroscopy. A first experimental study 
on this peptide by CD and FTIR measurements indicates that 
the preferred conformation of the peptide in the lipid environ-
ment is a (3-sheet structure [10]. However, in these experi-
ments, the unbound peptide was not separated from the in-
serted peptide, and the observed (3-sheet structure could be 
due to the aggregated population. In the case of HIV fusion 
peptide, the determining factor for an interaction of the pep-
tide with lipid membrane is the presence of PE in the bilayer 
as has been previously demonstrated [3]. HIV2 peptide indu-
ces release of PC/PE but not of egg PC or PC/PS vesicles and 
the presence of negatively charged lipid is not required. These 
results suggest that the first step of fusion process which is the 
binding of peptide to the lipid membrane is different for the 
viral infection and the sperm-egg fusion. 
Another argument to say that the mechanisms used by 
these two peptides to induce vesicle fusion are different is 
that a lipid such PE, which tends to destabilize the bilayer 
under certain conditions, allows the development of high fu-
sogenic activity of HIV fusion peptide but inhibits activity of 
fertilin peptide. Moreover, lysoPC which inhibits HIV fusion 
peptide-induced lipid mixing and calcein release has no effect 
on membrane fusion induced by fertilin fusion peptide. Our 
data demonstrate that fertilin fusion peptide-induced mem-
brane fusion does not proceed via non-lipid bilayer intermedi-
ates. In the case of HIV peptide, it has been demonstrated 
that it is the oblique orientation of the fusogenic peptide into 
the lipid bilayer that induces a negative curvature of the lipid 
membrane, favoring inverted micelle formation, catalyzing the 
fusion event [15,18]. Lysolecithin was shown to modify the 
peptide orientation in such a way that in its new orientation, 
parallel to the lipid-water interface, it prevents inverted mi-
30 40 
Temperature (°C) 
0 10 20 30 40 50 
LysoPC ug 
Fig. 3. Effect of temperature (A) and lysoPC (B) on the lipid mixing 
of LUV of PC/PE/SM/PS/PI/PA/Chol (17, 19, 20, 11, 2, 0.5, 30 
wt%) in presence of HIV2rod and fertilin fusion peptides. The per-
cent fusion values after 15 min were plotted as a function of tem-
perature or lysolecithin concentration. The final peptide and lipid 
concentration were 13 and 300 uM, respectively. In the presence of 
lysoPC, LUV (300 uM) and lysoPC (at different concentration) 
were preincubated at 37°C, pH 7.2 in HEPES buffer, for 15 min 
prior the addition of peptide (13 uM) 
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celle formation, curvature modification and therefore the fu-
sion process. 
In conclusion, this paper provides evidence that the fusion 
peptide from fertilin and that from HIV2 gp41 act by two 
different mechanisms. The role of PE and lysoPC in lipid 
mixing induced by HIV peptide is directly correlated with 
its capacity to induce the hexagonal phase during fusion proc-
ess. Since these two molecules have no effect on the fusion 
induced by fertilin peptide, we suggest that this peptide indu-
ces lipid mixing via another mechanism which does not need 
hexagonal phases as intermediary structures. A possible mech-
anism could require the formation of a t ransmembrane pore 
but this hypothesis has to be demonstrated. However, these 
differences have been detected only in model systems which 
have obvious limitations while many features of the biological 
system are not present. We can suggest that membrane fusion 
involved in viral fusion and sperm-egg fusion has a different 
molecular mechanism. Further studies are need to dissect 
these mechanisms. 
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